In silico analysis of deleterious SNPs of human MTUS1 gene and their impacts on subsequent protein structure and

Liza Teresa Rozario1, Tanima Sharker1, Tasnin Akter Nila2

  • 1Department of Biochemistry and Molecular Biology, Noakhali Science and Technology University, Noakhali, Bangladesh.

Plos One
|June 14, 2021
PubMed

Insights

The mitochondrial tumor suppressor 1 (MTUS1) gene is vital for preventing cancer. This study identified specific genetic variations (nsSNPs) in MTUS1 that may harm its function and contribute to stomach and endometrial cancers.

Area of Science:

  • Genetics
  • Bioinformatics
  • Oncology

Background:

  • The mitochondrial tumor suppressor 1 (MTUS1) gene is a critical regulator of cell growth and proliferation.
  • Downregulation of MTUS1 is linked to various cancers and human diseases.
  • Non-synonymous single nucleotide polymorphisms (nsSNPs) can alter protein structure and function, potentially impacting disease risk.

Purpose of the Study:

  • To computationally identify and differentiate deleterious nsSNPs in the MTUS1 gene from neutral ones.
  • To investigate the functional impact of nsSNPs on MTUS1 protein stability and conserved regions.
  • To correlate specific nsSNPs with cancer types.

Main Methods:

  • Utilized a suite of sequence and structure-based bioinformatics tools for in silico analysis.
  • Screened 215 nsSNPs within the MTUS1 gene using 7 prediction algorithms.
  • Evaluated nsSNPs based on their location in conserved regions and predicted effect on protein stability.

Main Results:

  • Identified 9 nsSNPs as potentially deleterious out of 215 analyzed.
  • Selected 5 nsSNPs (S1259L, E960K, P503T, L1084V, L1143Q) as damaging due to conserved location and reduced protein stability.
  • Found 2 nsSNPs (S1259L and E960K) associated with Stomach adenocarcinoma and Uterine corpus endometrial carcinoma, respectively.

Conclusions:

  • This study provides the first comprehensive in silico analysis of functional nsSNPs in the MTUS1 gene.
  • The identified potentially damaging nsSNPs offer valuable targets for future research and clinical applications.
  • Results can guide large-scale population studies, drug discovery, and the development of personalized medicine strategies for MTUS1-associated cancers.